Skip to main content
Premium Trial:

Request an Annual Quote

DnaNudge Inks Distribution Deal for SARS-CoV-2 Test, Other Products in Spain

NEW YORK — UK diagnostics firm DnaNudge said on Tuesday that it has signed an exclusive distribution agreement for its PCR-based SARS-CoV-2 test and other genetic testing products in Spain with Quirónprevención.

Under the terms of the deal, Madrid-based Quirónprevención will offer DnaNudge's CovidNudge, a CE-IVD-marked point-of-care assay for SARS-CoV-2. Quirónprevención — a part of Spanish hospital group Quirónsalud — will also distribute DnaNudge's nutrition service, which uses an individual's genetic profile to make eating recommendations, and its upcoming skincare service.

Financial and other terms of the agreement were not disclosed.

Last month, DnaNudge raised $60 million in private financing.

The Scan

Highly Similar

Researchers have uncovered bat viruses that are highly similar to SARS-CoV-2, according to Nature News.

Gain of Oversight

According to the Wall Street Journal, the Biden Administration is considering greater oversight of gain-of-function research.

Lasker for mRNA Vaccine Work

The Scientist reports that researchers whose work enabled the development of mRNA-based vaccines are among this year's Lasker Award winners

PLOS Papers on Causal Variant Mapping, Ancient Salmonella, ALK Fusion Test for NSCLC

In PLOS this week: MsCAVIAR approach to map causal variants, analysis of ancient Salmonella, and more.